北美血液透析和腹膜透析市场预测至 2028 年 - COVID-19 影响和按类型（血液透析和腹膜透析）、产品（设备、耗材和服务）和最终用户（医院和家庭）进行的区域分析
No. of Pages: 118 | Report Code: BMIRE00025835 | Category: Life Sciences
No. of Pages: 118 | Report Code: BMIRE00025835 | Category: Life Sciences
北美血液透析和腹膜透析市场
预计将从2022年的318.5239亿美元增长到2028年的452.7756亿美元；预计 2022 年至 2028 年复合年增长率为 6.0%。
肾病患病率上升疾病是推动北美血液透析和腹膜透析市场的主要因素。 慢性肾病 (CKD) 和急性肾损伤 (AKI) 是肾脏受损且无法正常过滤血液的疾病。因此，多余的液体和血液中的废物残留在体内，可能会导致其他健康问题，例如心脏病和中风。尽管治疗进展缓慢，但慢性肾病通常会随着时间的推移而恶化。如果 CKD 不及时治疗，可能会进展为肾衰竭和早期心血管疾病。在慢性肾病中，当肾脏停止工作时，需要透析或肾移植才能生存。当通过透析或肾移植治疗时，这种肾衰竭被称为终末期肾病（ESRD）。根据美国疾病控制与预防中心 (CDC) 的数据，美国约有 3600 万成年人患有 CKD。此外，每 24 小时就有 360 人开始因肾衰竭进行透析治疗。 2017 年，全球记录了 6.975 亿例 CKD（所有阶段）病例，北美患病率为 9.1%。
在过去几年中，透析的需求增加了。例如，根据国家肾脏基金会的数据，2018年，785,883名美国居民面临肾衰竭，其中554,038人接受透析。同样，根据美国食品和药物管理局公布的数据，美国药物管理局 (FDA) 称，美国约有 10,000 名儿童患有 AKI。这些儿童的存活率约为 38% 至 43%。
ESRD 患病率的增加也是推动市场的主要因素之一。例如，根据美国肾脏数据系统 (USRDS) 的数据，该国近 786,000 人患有终末期肾病 (ESKD)，也称为终末期肾病 (ESRD) ）。因此，慢性肾病、急性肾损伤和终末期肾病的患病率不断增加，导致透析状况的恶化，正在推动血液透析和腹膜透析市场的发展。
借助新功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动北美血液透析和腹膜透析市场的发展。北美血液透析和腹膜透析市场预计在预测期内将以良好的复合年增长率增长。
;
北美血液透析和腹膜透析市场细分
北美血液透析和腹膜透析市场按类型、产品、最终用户和国家/地区进行细分。根据类型，市场分为血液透析和腹膜透析。到2022年，血液透析领域预计将占据更大的市场份额。根据产品，血液透析和腹膜透析市场分为设备、耗材和服务。到 2022 年，服务领域可能会占据最大的市场份额。根据最终用户，市场分为医院和家庭。预计到 2022 年，以医院为基础的细分市场将占据更大的份额。根据国家/地区，北美血液透析和腹膜透析市场分为美国、加拿大和墨西哥。预计到 2022 年，美国将占据最大的市场份额。
旭化成医疗有限公司； B. 布劳恩梅尔松根股份公司；百特国际公司；达维塔公司；迪亚莱夫公司； Evoqua 水技术有限公司。 （Mar Cor 净化）；费森尤斯医疗保健公司两合公司；尼普罗医疗公司；和 Rockwell Medical, Inc. 是北美血液透析和腹膜透析市场的领先公司之一。
Strategic insights for North America Hemodialysis and Peritoneal Dialysis involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 31,852.39 Million |
| Market Size by 2028 | US$ 45,277.56 Million |
| Global CAGR (2022 - 2028) | 6.0% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Hemodialysis and Peritoneal Dialysis refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Hemodialysis and Peritoneal Dialysis Market is valued at US$ 31,852.39 Million in 2022, it is projected to reach US$ 45,277.56 Million by 2028.
As per our report North America Hemodialysis and Peritoneal Dialysis Market, the market size is valued at US$ 31,852.39 Million in 2022, projecting it to reach US$ 45,277.56 Million by 2028. This translates to a CAGR of approximately 6.0% during the forecast period.
The North America Hemodialysis and Peritoneal Dialysis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Hemodialysis and Peritoneal Dialysis Market report:
The North America Hemodialysis and Peritoneal Dialysis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Hemodialysis and Peritoneal Dialysis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Hemodialysis and Peritoneal Dialysis Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Hemodialysis and Peritoneal Dialysis Market
